To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI

NCT04955327 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Upper Respiratory Tract Infection

Interventions

DRUG: A. Paniculata
DRUG: A. Chilensis
DRUG: A. Paniculata and A. Chilensis
DRUG: Microcrystalline cellulose

Sponsor

Vedic Lifesciences Pvt. Ltd.